BRITISH NEURO-ONCOLOGY SOCIETY
Promoting research and raising awareness of neuro-oncology, treatments and techniques. Advocating for the interests of brain cancer patients and carers. Advancing education via an Annual Scientific Meeting.
Financial health, per its FY2025 accounts
The accounts state that the charity held £107,661 in unrestricted cash funds at the end of the period, a decrease from £130,185 in the prior year. The trustees consider there are no uncertainties about the charity continuing as a going concern. The charity aims to hold more than 12 months of operational spend in unrestricted cash reserves, equivalent to approximately £45,000.
What the accounts disclose
“Income is raised through membership fees and additional revenue is generated through the annual conference.”
“The charity aims to hold more than 12 months of operational spend in unrestricted cash reserves, equivalent to approximately £45,000 at 24/25 levels.”
Trustees
- Victoria Anne Skinnerchair
- Catherine Elisabeth Fraher
- Dr Harpreet Kaur Hyare
- Professor Colin Watts MBBS PhD
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/05/2025 | £26k | £49k |
| 31/05/2024 | £177k | £47k |
Common questions
Is BRITISH NEURO-ONCOLOGY SOCIETY financially healthy?
Per its FY2025 accounts: The accounts state that the charity held £107,661 in unrestricted cash funds at the end of the period, a decrease from £130,185 in the prior year. The trustees consider there are no uncertainties about the charity continuing as a going concern. The charity aims to hold more than 12 months of operational spend in unrestricted cash reserves, equivalent to approximately £45,000. Its FY2025 accounts were independently examined.